The article provides an analysis on stem-cell research with an overview of the leading companies doing stem-cell studies and the political landscape behind federal funding in the U.S. The author states that stem cells offer more specific targeting of diseases and has the potential to provide ...
Stem cell companies have been rapidly populating on a global basis, reaching hundreds of market competitors worldwide. Access the list here.
I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stem cell biotech stock ticker. The ticker is for some of the most widely held stem and cellular medicine companies. A sample screen shot is shown in this post. Quite a few stem cell-rela...
Not all state governments are sold on stem cell research. Initiatives in Illinois and Missouri, for example, have failed in recent weeks however. Granted, growth in public spending hasn't specifically translated into big stock gains for prominent stem cell companies. Geron (GERN), for example,...
Companies Covered Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34...
Some of the 12 companies featured in this Global Stem Cell Therapy Market report include: Advanced Cell Technology Anterogen, Ltd. Biotime, Osiris Therapeutics Cynata Cytori Therapeutics HolostemTerapieAvanzateS.r.l. ...
'This is a significant achievement of the team, one which we have been working towards for many years with the support of the University, our local hospital, and most importantly the Medical Research Council. We have succeeded where many substantial commercial companies have not. Many more xeno...
'This is a significant achievement of the team, one which we have been working towards for many years with the support of the University, our local hospital, and most importantly the Medical Research Council. We have succeeded where many substantial commercial companies have not. Many more xeno...
STML Stock Chart 1 Day 10 Day YTD 1 Year 5 Years STML Profile Stemline Therapeutics, Inc. (STML) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The company's lead product candidate is ELZONRIS, a targeted therapy...
canceledthe study a year later. Now it works on cancer drugs and no longer mentions embryonic stem cells on its website. Another stem-cell company, Sana, has seen its stock value droop since its 2021 IPO and last yearlaid off a teamtrying to create heart muscle to treat cardiac disease....